Skip to main content
Clinical Trials/NL-OMON45675
NL-OMON45675
Completed
N/A

Multiple Screening: a tool to identify cognitive deficits in individuals with Multiple Sclerosis in an early stage. The acquisition of normative data. - Multiple Screening for individuals with Multiple Sclerosis

Vrije Universiteit Medisch Centrum0 sites300 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
attention
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
300
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • The MS patients:
  • \- All patients are diagnosed with clinically definite MS following the revised McDonald criteria (Polman et al., 2011\).
  • \- Patients are at least 18 years of age
  • \- The patients are able to use an iPad.
  • \- Patients are willing to sign an informed consent prior to participation.;The healthy participants:
  • \- Healthy participants (no neurological and/or psychiatric illnesses) that are at least 18 years of age.
  • \- The participants are able to use an iPad.
  • \- The first sixty participants are willing to do both the digital as the paper\-and\-pencil version of the tests that are in the Multiple Screening app.

Exclusion Criteria

  • \- Neurological (other than MS for the patients) and psychiatric illnesses.
  • \- A history of drug\- and/or alcohol abuse (including present)
  • \- Inability to execute a neuropsychological examination on an iPad (e.g. due to eye\-related problems, fatigue, language barrier or motor difficulties.

Outcomes

Primary Outcomes

Not specified

Similar Trials